The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Eosinophilic and Neutrophilic Inflammation in Asthma: Insights from Clinical Studies
Abstract
Cellular inflammation of the airways with eosinophils and neutrophils is a characteristic feature of asthma and is considered relevant to the pathogenesis of the disease. Studies of large numbers of subjects with well-characterized asthma in recent years has resulted in new insights about the clinical and pathologic correlates of eosinophilic and neutrophilic inflammation in asthma. For example, eosinophilic asthma is a distinct phenotype of asthma that is associated pathologically by thickening of the basement membrane zone and pharmacologically by corticosteroid responsiveness. In contrast, noneosinophilic asthma, a sizeable subgroup of asthma that includes patients with severe disease, is not characterized by thickening of the basement membrane zone, and it appears to be relatively corticosteroid resistant. Eosinophilic and neutrophilic asthma are not mutually exclusive subtypes of asthma. Rather, neutrophils accumulate in the airways in patients with asthma with more severe airflow obstruction, where eosinophils may also be present in excess. In addition, neutrophils are prominent in airway secretions during acute severe asthma exacerbations, where it is possible that they have roles in both the initiation and resolution of attacks. These insights about the relationships between cellular inflammation and disease phenotypes of asthma support the concept that different subgroups of patients with asthma, despite clinically similar features, can be defined by specific cellular and molecular markers. The promise now is that these markers will ultimately guide personalized treatment programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Eosinophilic Inflammation in Asthma
Bousquet, J., Chanez, P., Lacoste, J. Y., Barnéon, G., Ghavanian, N., Enander, I., Venge, P., Ahlstedt, S., Simony-Lafontaine, J., Godard, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231505 · Cited by 2,499
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Mucosal Inflammation in Asthma
Djukanović, R., Roche, W. R., Wilson, J. W., Beasley, C. R. W., Twentyman, O. P., Howarth, P. H., & Holgate, S. T. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.2.434 · Cited by 1,280
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Self-citationWENZEL, S. E., SZEFLER, S. J., LEUNG, D. Y. M., SLOAN, S. I., REX, M. D., & MARTIN, R. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9610046 · Cited by 754
Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
Fahya, B., Kimb, K. W., Liub, J., & Bousheya, B. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70128-1 · Cited by 678
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Jayaram, L., Pizzichini, M. M., Cook, R. J., Boulet, L.-P., Lemière, C., Pizzichini, E., Cartier, A., Hussack, P., Goldsmith, C. H., Laviolette, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00137704 · Cited by 603
The Relationship between Airways Inflammation and Asthma Severity
LOUIS, R., LAU, L. C. K., BRON, A. O., ROLDAAN, A. C., RADERMECKER, M., & DJUKANOVIĆ, R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9802048 · Cited by 571
Efficacy and Safety of Inhaled Corticosteroids in Asthma
Barnes, P. J., & Pedersen, S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_2.s1 · Cited by 523
Cox, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4719 · Cited by 505
Berry, M., Morgan, A., Shaw, D. E., Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2007) · Thorax · doi:10.1136/thx.2006.073429 · Cited by 483
O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans
Seltzer, J., Bigby, B. G., Stulbarg, M., Holtzman, M. J., Nadel, J. A., Ueki, I. F., Leikauf, G. D., Goetzl, E. J., & Boushey, H. A. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.4.1321 · Cited by 476
ORDOÑEZ, C. L., SHAUGHNESSY, T. E., MATTHAY, M. A., & FAHY, J. V. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9812061 · Cited by 437
Self-citationCD4+ Invariant T-Cell–Receptor+ Natural Killer T Cells in Bronchial Asthma
Akbari, O., Faul, J. L., Hoyte, E. G., Berry, G. J., Wahlström, J., Kronenberg, M., DeKruyff, R. H., & Umetsu, D. T. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053614 · Cited by 422
Epithelium: At the interface of innate and adaptive immune responses
Schleimer, R. P., Kato, A., Kern, R., Kuperman, D., & Avila, P. C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.046 · Cited by 377
Corticosteroid reversibility in COPD is related to features of asthma.
Chanez, P., Vignola, A. M., O'Shaugnessy, T., Enander, I., Li, D., Jeffery, P. K., & Bousquet, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154853 · Cited by 297
Bronchial Neutrophilia in Patients with Noninfectious Status Asthmaticus
LAMBLIN, C., GOSSET, P., TILLIE-LEBLOND, I., SAULNIER, F., MARQUETTE, C.-H., WALLAERT, B., & TONNEL, A. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.97-02099 · Cited by 296
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Saha, S. K., Berry, M. A., Parker, D., Siddiqui, S., Morgan, A., May, R., Monk, P., Bradding, P., Wardlaw, A. J., Pavord, I. D., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.005 · Cited by 255
Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma
Shaw, D. E., Berry, M. A., Hargadon, B., McKenna, S., Shelley, M. J., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2007) · Chest · doi:10.1378/chest.07-1047 · Cited by 238
Invariant Natural Killer T Cells in Asthma and Chronic Obstructive Pulmonary Disease
Vijayanand, P., Seumois, G., Pickard, C., Powell, R. M., Angco, G., Sammut, D., Gadola, S. D., Friedmann, P. S., & Djukanović, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064691 · Cited by 192
Humbert, M., Ying, S., Corrigan, C., Menz, G., Barkans, J., Pfister, R., Meng, Q., Van Damme, J., Opdenakker, G., Durham, S. R., et al. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998072 · Cited by 159
Cited by
Type 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro
Benam, K. H., Villenave, R., Lucchesi, C., Varone, A., Hubeau, C., Lee, H.-H., Alves, S. E., Salmon, M., Ferrante, T. C., Weaver, J. C., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3697 · Cited by 816
Targeting key proximal drivers of type 2 inflammation in disease
Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Self-citation
Metadata
- Authors
- Fahy, J. V.
- Venue
- Proceedings of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-01
- Volume
- 6
- Issue
- 3
- Pages
- 256-259
- ISSN
- 1546-3222 (ISSN-L)
- 1943-5665
- OpenAlex
- W1992622607
- Cited by
- 389
- References
- 27
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.